← View as cluster
Thread · March 22, 2026

Analyst Dan Ives Hails Terafab as Path to Tesla-SpaceX Merger and $600 PT

Wedbush's Dan Ives views Terafab as accelerating Tesla's AI strategy amid chip shortages, positioning it as an AI powerhouse and first step toward a 2027 Tesla-SpaceX merger. Maintains Outperform rating with $600 TSLA target despite uncertain timeline. Notes suppliers like TSMC can't meet demand.

Key facts

  • First step to Tesla-SpaceX merger in 2027
  • $600 TSLA price target
  • Addresses chip supply constraints for AI
this is the first step to ultimately what will be Tesla and SpaceX combining forces in a merger likely in 2027
— Dan Ives

How the story unfolded

  1. 1 source
  2. 1 source
  3. 1 source
  4. 2 sources
  5. 1 source
  6. 7 sources
  7. 10 sources
    Show 5 more sources
  8. 5 sources
  9. 13 sources
    Show 8 more sources
  10. 5 sources
  11. 5 sources
  12. 3 sources
  13. 1 source
  14. 1 source
  15. 1 source
  16. 1 source
  17. 1 source
  18. 1 source
  19. 1 source
  20. 1 source
  21. 2 sources
  22. 1 source
  23. 1 source
  24. 1 source
  25. 1 source
  26. 2 sources
  27. 3 sources
  28. 3 sources
  29. 1 source
  30. 1 source
  31. 3 sources
  32. 7 sources
  33. 1 source
  34. 1 source
  35. 3 sources
  36. 6 sources
  37. 19 sources
  38. 7 sources
  39. 1 source
  40. 1 source
  41. 5 sources
  42. 4 sources
  43. 1 source
  44. 1 source
  45. 1 source
  46. 4 sources
  47. 1 source
  48. 4 sources
  49. 1 source
  50. 2 sources
  51. 2 sources